These modifications are also believed to assist at least 90% of the peptide to bind covalently to blood albumin, with trace amounts potentially binding to fibrinogen and immunoglobulin G (IgG)
The AAFP advises that injectable therapy leads to more rapid improvement and should be considered in patients with severe deficiency or severe neurologic symptoms (Langan RC, Goodbred AJ, 2017)
However, recent discoveries have expanded its relevance beyond metabolic health
These include the individual's current health status, metabolism, weight loss goals, and any underlying medical conditions
Changes in body composition can affect insulin sensitivity independently
Patients should be counselled about the importance of adherence to their maintenance schedule